Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasma

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We present a new functional assay for the first complement component (C1) in plasma, based on its activation by inhibition of the C1-esterase inhibitor (C1-inh) when monospecific antiserum to C1-inh is added to the plasma. After maximal activation, we can determine the concentration of activated C1 by using an amidolytic rate assay with a chromogenic substrate. We have optimized the assay conditions with respect to incubation time, concentration of antiserum to C1-inh, ionic strength, and pH. Our method determines specifically the concentration in plasma of free activated C1, not complexes of activated C1 with C1-inh, and is not influenced by the concentration of C1-inh in the test sample. Concentrations of C1 correlated significantly with activities determined by a hemolytic assay (r = 0.55, t = 4.09, P <0.001). The estimated interassay CV was 5% and the intra-assay CV was 1%. The sensitivity, imprecision, and practical test performance of our assay are superior to those of conventionally used hemolytic assays.

Cite

CITATION STYLE

APA

Munkvad, S., Jespersen, J., Sidelmann, J., & Gram, J. (1990). Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasma. Clinical Chemistry, 36(7), 1305–1311. https://doi.org/10.1093/clinchem/36.7.1305

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free